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Abstract
Background: Uncorrected refractive errors are the commonest cause of visual loss in children despite spectacle
correction being highly cost-effective. Many affected children do not benefit from correction as a high proportion do not
wear their spectacles. Reasons for non-wear include parental attitudes, overprescribing and children being teased/bullied.
Most school programmes do not provide health education for affected children, their peers, teachers or parents.
The Portable Eye Examination Kit (Peek) will be used in this study. Peek has applications for measuring visual acuity with
software for data entry and sending automated messages to inform providers and parents. Peek also has an application
which simulates the visual blur of uncorrected refractive error (SightSim).
The hypothesis is that higher proportion of children with uncorrected refractive errors in schools allocated to the Peek
educational package will wear their spectacles 3–4 months after they are dispensed, and a higher proportion of children
identified with other eye conditions will access services, compared with schools receiving standard school screening.
Methods/Design: Cluster randomized, double-masked trial of children with and without uncorrected refractive errors
or other eye conditions. Government schools in Hyderabad, India will be allocated to intervention (Peek) or comparator
(standard programme) arms before vision screening. In the intervention arm Peek will be used for vision screening,
SightSim images will be used in classroom teaching and will be taken home by children, and voice messages will be
sent to parents of children requiring spectacles or referral.
In both arms the same criteria for recruitment, prescribing and dispensing spectacles will be used. After 3–4 months
children dispensed spectacles will be followed up to assess spectacle wear, and uptake of referrals will be ascertained.
The cost of developing and delivering the Peek package will be assessed. The cost per child wearing their spectacles or
accessing services will be compared.
Discussion: Educating parents, teachers and children about refractive errors and the importance of wearing spectacles has
the potential to increase spectacle wear amongst children. Innovative, potentially scalable mobile technology (Peek) will be
used to screen, provide health education, track spectacle wear and adherence to follow-up amongst children referred.
Trial registration: Controlled-Trials.com, ISRCTN78134921. Registered on 29 June 2016.
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Background
Uncorrected refractive errors (uRE) are the commonest
cause of visual loss in children.
The proportion of visual impairment due to uREs,
defined as ≤6/12 in the better eye, in a group of standard-
ized studies of children aged 5 to 15 years was 56.0% in
Nepal [1], 56.3% in Chile [2], 61.0% in rural India [3],
63.6% in South Africa [4], 81.7% in urban India [5], 87.0%
in Malaysia [6], 89.5% in rural China [7] and 94.9% in
urban China [8]. Correcting refractive errors (RE) is highly
cost-effective [9–11]. It is estimated that 12.8 million
children worldwide are visually impaired from uRE [12].
Refractive errors can result from the axial length of the
eye being too long or too short, and from abnormalities in
the curvature of the cornea. The three most common types
of REs are myopia (short-sightedness), hypermetropia
(long-sightedness) and astigmatism (distorted vision at dis-
tance and near). Myopia is the commonest type of RE [13].
The onset is usually around the age of 8 years and increases
in severity throughout adolescence [13]. Myopia is far more
common in Southeast Asian children, where the age of
onset is earlier and progression more rapid [13]. There is
increasing evidence of the impact of correcting RE in
children, with improvement in social development, quality
of life, visual functioning and academic performance [14].
In India, there are approximately 140 million children
aged 11–15 years, 5.6 million (4%) of whom have uRE
and would benefit from spectacles. Correction of REs is
a priority of the Government of India [15]. However, a
high proportion of children who could benefit from RE
correction do not wear their spectacles [16], reported as
only 30% in a recent study in India [17]. There are many
reasons for non-wear, including parents not purchasing
spectacles, overprescribing and children being teased and
bullied or not liking their spectacles [16]. Some parents
fear that spectacles will weaken their child’s eyes, are
expensive and are stigmatizing, or indicate that their child
has a disability [18]. In India, some programmes have
trained teachers to screen vision, but teachers are not
usually otherwise engaged in the process and they usually
do not promote or monitor spectacle wear. It is not stand-
ard practice in India to send explanatory pamphlets to
parents of children requiring spectacles and parents are
not typically made aware of the benefits of spectacle wear.
There have been three trials of interventions to im-
prove spectacle wear: an education intervention of stu-
dents in China, which had negative results, showing that
educating children alone is not effective [19]. Another
recent trial in China had a factorial design with six sub-
groups. Children in half the schools were randomized to
a health education intervention, which involved showing
children a 10-minute documentary-style video, a booklet
of cartoons, and classroom discussion led by teachers.
The same schools were randomized to three approaches
to providing spectacles i.e. free spectacles, a voucher, or
children were given a prescription for spectacles. Spec-
tacle wear was assessed by observation and self-report.
Observed wear was higher in all four subgroups ran-
domized to the health education intervention (RR 1.46
to 1.74) [14]. The other trial was of free versus low-cost
spectacles in Tanzania, in which free spectacles almost
doubled wearing rates [18].
A recent trial by the investigators in Bangalore, India
showed that 2.6% of children aged 11–15 years had signifi-
cant uRE, defined as a level of visual loss due to RE which
improved by two or more lines of Snellen visual acuity
(VA) in one or both eyes with spectacle correction. In this
study, children could select the spectacle frames they
preferred and almost 75% were wearing their spectacles at
unannounced visits 3–4 months later [20].
Mobile phone technology is a rapidly expanding area
in health care [21], including eye care [22]. A recent
development, the Portable Eye Examination Kit (Peek)
[23] has a suite of applications (apps), including for
measuring VA [24] which has been found to be an
acceptable tool for patients, examiners and stakeholders
in a recent study in Kenya [25]. The Peek School Screen-
ing system enables automated text and voice messaging to
parents/guardians and contact teachers as well as real-
time notifications to refractive or hospital services of
screened positive children who require further assessment
or follow-up. Peek also has an app which generates images
that simulate the visual blur associated with uRE (Sight-
Sim). (See Additional file 1: Figure S1.) A recent trial in
schools in Kenya using the system demonstrated that
teachers could be taught to screen VA reliably using the
Peek app, and SightSim images (Polaroid photographs)
and text messages were sent to parents. Uptake of referrals
to eye care providers was two and a half times higher in
the Peek intervention arm of the trial (unpublished data).
Research on why children with significant refractive
errors do not wear their spectacles is limited, but the
available evidence highlights the importance of environ-
mental factors, particularly the negative attitudes of
others i.e., peers, parents, the wider family and teachers,
as well as community norms and attitudes [26, 27].
There are multiple theories and constructs which can be
used to describe behavior or to bring about behavior
change, and the Social Ecological Model (SEM), which
describes five nested, hierarchical levels which influence
behavior i.e., individual, interpersonal, organizational,
community and public policy, has been adopted in this
study as it encapsulates the main factors which influence
spectacle wear among children [28]. The SEM empha-
sizes that it is easier to adopt healthier behaviors by
bringing about change in the environment, by using the
example of role models, and by reinforcement. In the
trial being planned, SightSim images of relevance to
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Indian children aged 11–15 years will be used, including
images of role models such as sports personalities, and
used in classroom teaching so that all children as well as
teachers learn about the impact of uRE and the impact
of correction. Children identified who need spectacles
will also take home a SightSim image of their choice to
show their parents, which demonstrates how much
clearer their child’s world would be if they wore their
spectacles. Messages will be reinforced to parents
through voice messages send to their mobile phones.
Purpose
The purpose of this cluster randomized trial is to evaluate
whether a health education package for teachers, parents
and children (aged 11–15 years), delivered using Peek
increases spectacle wear at 3 to 4 months and uptake of
referral of children identified with other eye conditions.
The trial will also assess the cost of developing and deliv-
ering the Peek health education intervention and the cost of
dispensing and delivering the spectacles in both arms of the
trial. The cost per child wearing their spectacles at follow-up
will be compared between the two arms of the trial.
The hypothesis is that the proportion of children wear-
ing spectacles 3–4 months after they were given their
spectacles is higher in schools allocated to the innovative
Peek educational package than in schools randomized to
the standard programme. The uptake of referrals is also
anticipated to be higher in the schools allocated to the
Peek educational package than those randomized to the
standard programme.
Formative research and pilot study November 2016
Formative research including a pilot study will be under-
taken in non-trial schools to test all aspects of the trial,
including which SightSim images to use and the content
of voice messages to parents to remind them to encour-
age their children to wear their spectacles, or to access
services. The formative research will use mixed methods,
including focus group discussions separately with head
teachers, parents of both boys and girls of different ages
and also boys and girls of different ages. Focus group
discussions with head teachers will gather their views of
spectacle wear by children, views on using SightSim
images to increase awareness among parents, and which
images they consider the most suitable for parents.
Based on data from the focus group discussions,
images will be selected for classroom teaching. These
classroom education materials will be shown to children
and they will be asked to give their opinion on activities
that children with uncorrected refractive error might like
to do but cannot do because they do not have clear
enough vision. Children will be shown SightSim images
of the visual blur experienced by children with uRE and
they will be asked to express their reactions. Classroom
teachers will also be asked to comment on the images
suggested.
A short questionnaire to assess children’s knowledge
of and attitudes towards spectacle wear will be assessed
immediately before and after a session of classroom
teaching using SightSim images. In each school, two
classes of different ages will be administered the ques-
tions before and after classroom teaching, a total of
approximately 200 children aged 11–15 years.
Methods/design
The trial is designed as a cluster randomized, double-
masked clinical trial of children with and without uRE in
accordance with the Standard Protocol Items: Recom-
mendations for Interventional Trials (SPIRIT) guidelines
[29]. Children will be masked to the allocation as they
will not be told that other schools will have a different
intervention, and field workers who collect the data for
the primary outcome will also be masked to the hypoth-
esis and intervention arm.
Study setting
The trial is being undertaken in government middle and
secondary schools in urban and rural areas in and around
Hyderabad, Telangana State, India. The trial is being coor-
dinated by the Public Health Foundation of India (PHFI),
Hyderabad. The team consists of a programme manager,
administrator, optometrists, dispensing opticians, field
workers and ophthalmologists. Training, quality assurance
and oversight of data collection are being provided by staff
at the International Centre for Eye Health, London School
of Hygiene & Tropical Medicine (LSHTM).
Participant eligibility
Selection of schools
A list of government secondary schools will be obtained
from the District Block Education Officer. The precise loca-
tion of each school will be determined using Google Maps.
Schools will be excluded if they already have school eye
health programmes where screening took place within the
previous 2 years, or are single-gender schools. If two
schools are less than 10 km apart one will be excluded at
random. Schools will be stratified by location (urban/rural)
and size (more or less than 200 children aged 11–15 years).
The head teacher of each selected school will be visited by
a field worker to obtain written informed consent for the
school to participate. An information sheet in the local lan-
guage with an opt-out option will be given to each child
aged 11–15 years for them to take home. Parents will be
given the option to opt out entirely i.e., that their child is
not screened, or to opt out from being recruited to the trial.
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Inclusion criteria
There are two mutually exclusive eligibility criteria in
this study i.e. for spectacle correction and for referral.
Common criteria for both are that children are aged 11–
15 years inclusive, parents’ consent for their child to take
part in the study and the child proves assent, and they
have a presenting VA (i.e. with spectacles if usually
worn) of less than 6/9.5 in one or both eyes. Children
will be eligible for immediate spectacle correction if their
binocular VA with full correction improves by two or
more lines. Children will be eligible for referral if they
require cycloplegic refraction, if their presenting VA is
6/60 or less in one or both eyes regardless of the cause,
if their best-corrected visual acuity does not improve by
two or more lines in both eyes or they require further
investigation for any other non-refractive eye conditions.
Exclusion criteria
Children will not be recruited if parents do not consent or
the child does not assent. Children whose parents agree
that they can be screened will be assessed and spectacles
dispensed if required, or they will be referred, but will not
be recruited to the trial. Children whose parents opt out
entirely, but where the teacher suspects a problem will be
given a letter to take home.
Eligibility of those performing interventions
All refractions, prescribing and dispensing are being
undertaken by fully qualified optometrists, with training
and quality checks by the lead investigator. All screen-
ing, delivery of spectacles and follow-up at 3–4 months
will be conducted by trained field workers.
Identification of potential participants and recruitment
In the intervention arm, field investigators in the school
identified by the head teacher will first undertake class-
room teaching using the SightSim images for all children
aged 11–15 years, after training. A training manual will be
developed to standardize the delivery. Field workers will
be trained in each school to screen VA using the Peek vi-
sion screener app at the Snellen equivalent 6/9.5 level of
VA, and children aged 11–15 years will be screened. To
pass vision screening a child needs to correctly see four or
five of five consecutive E optotypes. Once screening has
been completed, all those who fail will be automatically re-
ferred to a visiting optometrist and will be refracted on
the same day. Attendance will be checked against the data
in the Peek software. After identifying children requiring
spectacles each child will select a SightSim image of their
choice from a range of images, which they will be asked to
take it home to show their parents.
In the schools allocated to the comparator arm,
trained field workers will screen VA using a standard
card-based E optotype at the 6/9.5 level at 6 meters. To
pass at the 6/9.5 level children need to correctly indicate
the orientation of the E in at least four out of five opto-
types. No health education materials or voice messages
will be sent to the parents (Fig. 1).
To standardize data recording, data will be entered using
dedicated Peek software in both arms of the trial. The soft-
ware will have range and consistency checks built in. Field
workers and optometrists working in schools in both arms
of the trial will be given tablets for data entry, and data will
be regularly backed up onto a cloud server. In both arms of
the trial the head teacher will be given a list of all the
children in their school who require spectacles or referral.
Classroom teachers will also be given a list of children in
their class who require spectacles or referral.
The following information will be collected by trained
field workers by interviewing all eligible children in both
arms of the trial: name, age, gender, class and date of
birth; parents’ mobile phone number, language used in
the home; parental education; occupation of parents;
whether one or both parents wear spectacles for distance
vision and limited information on household assets
taken from National Household Survey questionnaires.
Data on subjective refraction and best-corrected VA in
each eye will be recorded as well as the prescription of
the spectacles required and the frame the child selected
from a selection of thirteen plastic frames of different
colours. In the intervention arm, the SightSim image the
child selects to take home will be recorded.
In both groups of schools, only children with significant
REs will be prescribed spectacles i.e., where after correc-
tion, the acuity improves by two or more lines binocularly.
Children will select the frames they prefer from a range of
coloured plastic frames. Each pair of spectacles will have a
unique code. Spectacles will be delivered to the schools by
field workers at no cost as soon as possible and all chil-
dren in each school will receive their spectacles on the
same day. At the school, field workers will double-check
the name of each child against the lists given to classroom
teachers, to ensure that each child receives the correct
spectacles. The field workers will measure children’s VA
with their new spectacles.
In both arms of the trial, children with other eye
conditions will be referred using a referral slip indicating
their study ID, name and school, indicating that assess-
ment and treatment will be provided at no cost at Push-
pagiri Eye Institute on presentation of the referral slip.
An administrator will be appointed at Pushpagiri Eye
Institute who will access lists generated by Peek software
of all children referred. The administrator will enter the
date of attendance of children who attend Pushpagiri
Eye Institute into Peek software for children referred
from the intervention and comparator arms of the trial.
In the intervention arm of the trial, voice messages will
be sent to parents of children requiring spectacles in the
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local languages within 1 week of their child being given
their spectacles and again every 2 weeks for 3 months.
Reminder messages will also be sent to parents of chil-
dren referred within 1 week of referral and again every
2 weeks for 3 months if their child has not attended.
Fieldwork has been planned such that the initial as-
sessment, delivery of spectacles and follow-up 3–4
months later do not coincide with school examination
periods, long school holidays, nor the end of the school
year when children may leave or change schools.
If the Peek education package is found to be superior to
the control schools, the same package will be delivered
after the 3–4 month follow-up.
Participant timeline and study flowchart
The study flowchart and participant timeline are presented
in Figs. 1 and 2, respectively. A filled Standard Protocol
Items: Recommendations for Interventional Trials (SPIRIT)
checklist is available (see Additional file 2).
Intervention and comparator arm
The intervention will be the Peek Acuity health educa-
tion package. The comparator will be a standard school
screening programme where no health education mate-
rials or messages are sent to parents (standard care)
(Table 1).
Sample size calculation
A superiority margin of 20% was chosen to balance the an-
ticipated higher costs of developing and delivering the Peek
package. We estimate that we will need a study size of 450
children (225 in each arm) to detect a difference of 20% in
spectacle wear between the intervention and comparator
arm, assuming approximately 60% of children in the con-
trol arm will be wearing spectacles at follow-up, with a 95%
Fig. 1 Study flowchart
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confidence interval and 90% power. We have adjusted the
sample size calculations for clustering using data from our
previous study (unpublished) to estimate a design effect of
1.5. We have increased the sample size by 20% to allow for
loss to follow-up. A total of 17,300 children will need to be
screened to recruit 450 children for this trial. The commu-
nities are stable and few study children are expected to
leave the school during the school year.
This will detect a 20% difference in spectacle wearing, de-
termined using the sampsi command in Stata Statistical
Software version 14 (StataCorp, College Station, TX, USA).
Randomization
A list of schools where the head teachers has given
permission will be prepared in India (PM) and each
school will be allocated a unique ID. All clusters will be
randomized at once so allocation concealment will not
be an issue. The schools will be randomized using a
web-based randomization service (Sealed Envelope Ltd.
2016. Simple randomisation service [Online]). Available
from: https://www.sealedenvelope.com/simple-randomi-
ser/v1/ [Accessed 3 Jan 2017])
The schools will be randomly allocated to intervention
or comparator arm, stratified by size, i.e. the number of
children enrolled at the school between the age 11–15
years. To reduce contamination, schools will be allocated
to the intervention and control arm and not individual
children, and study schools will not be closer than 10 km
to minimize contact between children in the different
arms of the trial. Recruitment bias will be unlikely because
all children who fail screening i.e. who have a VA of less
than 6/9.5, will have similar procedures thereafter, i.e.
refraction, dispensing spectacles or referral, apart from the
health education intervention, which will be applied after
recruitment. Figure 1 is a flowchart showing a child’s
journey and the activities involved from screening, to
deciding whether they are eligible for recruitment, then
randomization and follow-up.
Primary outcome
The primary outcome is defined as the proportion of chil-
dren who are wearing their spectacles at an unannounced
visit to the school 3 to 4 months after delivery of the
spectacles. A new field worker will be recruited and trained
to collect the primary outcome data who will be masked to
the hypothesis and intervention arm. Spectacle wear will be
ascertained using the four categories defined by Wedner
[18] where categories 1 or 2 below define spectacle wearing,
and categories 3 or 4 as non-spectacle wearing: (1) wearing
the spectacles at the time of the unannounced visit, (2) not
wearing the spectacles at the time of the visit but have them
at school, (3) not wearing the spectacles at the time of the
visit but said they are at home, and (4) not wearing the
spectacles at the time of the visit as they are broken or lost.
Secondary outcome
Uptake of referral to Pushpagiri Eye Institute, which will
be assessed 4–5 months after screening.
STUDY PERIOD
Enrolment Allocation Post-allocation Close-out
TIMEPOINT -t2 -t1 0 t1 t2 t3 t4
ENROLMENT:
Approvals: district 
education officer 
and head teachers
X
Informed consent: 
parents X
Qualitative tools 
development
X
Eligibility screen X
Allocation X
INTERVENTIONS:
Peek package: 
Sightsim images & 
voice messages to 
parents
Standard care X X
ASSESSMENTS:
Spectacle wear
Uptake of referrals
X X
Fig. 2 SPIRIT timeline
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Other outcomes
At follow-up, each child not wearing their spectacles will
be asked why they are not wearing them. Children wear-
ing spectacles will be asked why they are wearing them.
They will be asked if there is a second reason. Their re-
sponse will be written down verbatim by field workers
and coded afterwards, with reasons for non-wear likely
to fall into the following categories: (1) never received
them, (2) lost, (3) broken or scratched, do not like wear-
ing them because (4) they were teased, or (5) appear-
ance, or (6) headache or eye strain; (7) parents do not
like the child to wear them, (8) did not notice an im-
provement in vision i.e. no benefit and (9) other, which
will be specified.
The costs of developing the Peek education package,
and for delivering both arms of the trial, will be deter-
mined using standard costing methods and data from
Peek software developers. The cost per child wearing
their spectacles at follow-up will be calculated and com-
pared between arms.
Data management
All data from both arms of the trial will be entered and
stored in the Peek database. Data will be transferred into
Stata for analysis.
All field staff will undergo rigorous training in using
Peek for screening and entering and recording data.
Inter-observer agreement studies will be done for VA
screening and refraction.
The Peek Acuity database will be password protected. At
the end of the study, the data will be archived at LSHTM.
Data analyses
Analysis will be in the groups to which children were
randomly allocated. We expect all children will be given
the spectacles required.
Primary outcome
The proportion of children wearing or having their
spectacles with them at school at 3 to 4 months will be
compared between the intervention and standard arms
using the risk difference with 95% confidence intervals
adjusted for cluster (school).
A separate analysis will also be undertaken to adjust for
factors that may affect spectacle wear such as gender, age
(linear term), degree of refractive error in the better seeing
eye (linear term), previously wore spectacles (binary data),
parental spectacle wear (binary data) and educational level
(categorical data) if there are imbalances between the two
arms of the trial. There will be no subgroup analysis.
In the Peek software the name of the school will never
be entered, only the school study ID and the allocation
code. The same applies to schools in the comparator
arm. Schools will, therefore, only be identified by ID
number while the data are being analysed.
Masked analysis of the primary outcome will be difficult
as the database for schools allocated to the intervention
arm will a larger number of fields than the comparator
arm e.g., the SightSim image the child took home; the
number and date of voice messages sent to parents.
Secondary outcomes
The proportion of children who access eye care after re-
ferral to Pushpagiri Eye Institute will be compared be-
tween arms, using the risk difference with 95%
confidence intervals adjusted for cluster (school).
Other outcomes
Reasons for non-spectacle and spectacle wear will be
compared between the two arms of the trial, after
categorizing their responses.
Data on the cost per child wearing their spectacles at
follow-up will only be analysed should the difference in
spectacle wear be 20% or greater in the intervention arm.
Table 1 An overview of the two arms of the trial
Intervention arm Comparator arm
Age group 11–15 years 11–15 years
Screening
VA level
<6/9.5 in one or both
eyes
<6/9.5 in one
or both eyes
Method of
screening
Peek E Acuity by field
workers
E card optotype
by field workers
Health education • SightSim images for
classroom teaching by
field workers, after
orientation i.e. for all children
None
• Eligible children will select
a SightSim image of their
choice from a range of
pre-tested images to take
home to show their parents
with wording in the relevant
local language
• Personalized voice messages
for parents in the relevant
local language
Refraction Trained optometrist Trained
optometrist
Definition of
significant RE
Same in both arms
of the trial
Same in both
arms of the trial
Dispensing
criteria
Same in both arms
of the trial
Same in both
arms of the trial
Frame types Same in both arms
of the trial
Same in both
arms of the trial
Delivery of
spectacles
Same in both arms
of the trial
Same in both
arms of the trial
Assessment of
primary outcome
Same in both arms
of the trial
Same in both
arms of the trial
VA visual acuity, Peek Portable Eye Examination Kit, RE refractive errors
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Data monitoring
A data monitoring committee will not be required.
There is no reason to expect significant adverse effects.
Interim analyses are not planned.
Harms
Neither arm of the trial has any anticipated harms. If
spectacles are prescribed inaccurately, or fitted incor-
rectly, they can cause blurred vision and/or eyestrain or
headaches whilst using the spectacles. In this trial all
refractions and spectacle fittings will be undertaken by
highly experienced optometrists to ensure inaccurate
prescribing is unlikely. When children are followed up at
3–4 months, they will be asked whether these symptoms
were the reason they did not wear their spectacles. If a
child reports any of these symptoms, they will be
refracted again and given new spectacles if required.
Dissemination
Findings will be reported using CONSORT guidelines
for cluster randomized trials. All investigators will con-
tribute to the dissemination strategy, which is likely to
include a summary of the findings for the local Steering
Committee, head teachers, a report for the website of
participating institutions, publications in peer-reviewed
journals, presentation at national (UK and India) and
international conferences.
Protocol amendment
Important protocol modifications, such as eligibility cri-
teria, will be reported to the Interventions Research Ethics
Committee, LSHTM, the Institutional Ethics Committee
at Public Health Foundation of India, the Indian Council
of Medical Research and Controlled-Trials.com.
Consent
Approval for the trial will be sought from the relevant
school authorities, including the District Education Offi-
cer and by the lead collaborator in India. Written in-
formed consent will be obtained from head teachers,
who will be given copies of the information sheet and
signed consent forms.
Parents of all children to be screened will be sent an in-
formation sheet via the children explaining that their
child’s vision will be tested, and they will be given
spectacles, if required. Parents will be allowed to opt out.
If on the day of screening children whose parents have
opted out still want to be screened, the child will be given
an assent form to sign which will be countersigned by the
head teacher. The child will be given a copy to take home.
They will then be screened and given spectacles, if re-
quired, but will not be recruited to the trial. The school
ID of these children will be entered into the Peek software
and they will be given a child ID of 00.
All children recruited to the trial will be given verbal infor-
mation in the local language about the study and an explan-
ation of the procedures by trained field workers. They will
also be given an opportunity to ask questions at the time.
All the information sheets and consent forms will be
translated into local languages (Hindi and Telugu).
Confidentiality
Data will be kept confidential as no identifiers will be en-
tered into the Peek database. Data will be anonymized by
allocating a unique study ID for each school and each par-
ticipant. The Peek database will be password protected. At
the end of the study, the data will be archived at LSHTM.
All data will be made readily available in a public do-
main after the initial analyses and results are published.
Access to data
Only investigators at LSHTM and the lead investigator
at PHFI will have access to the final trial dataset. A
memorandum of understanding will be drawn up be-
tween the two institutions highlighting intellectual prop-
erty issues, which will include data sharing and
availability of the data at the end of the study.
Post-trial care
Given that myopia can progress during adolescence it is
recommended that school vision screening be repeated
every 2 years for this age group. This ensures that chil-
dren whose spectacles require replacing are identified
and children entering the school system for the first time
are screened. This process can be put into place with
support from Pushpagiri Eye Hospital and the local edu-
cation authorities.
Discussion
This trial is designed to evaluate whether a health educa-
tion package for teachers, parents and children delivered
using innovative mobile phone technology (Peek) in-
creases spectacle wear at 3 to 4 months, as well as the
uptake of referral of children identified during vision
screening with other eye conditions. We will also assess
the cost of developing and delivering the health educa-
tion intervention in the intervention arm of the trial,
and the cost of dispensing and delivering the spectacles
in both arms of the trial. We will compare the cost per
child wearing their spectacles at follow-up in both arms.
The Government of India recognizes the importance
of correcting RE in children as they are included in the
national programme for child health, called Rashtriya
Bal Swasthya Karyakram (RBSK), and the National
Program for the Control of Blindness. The health of
schoolchildren is also recognized by international health
experts, policy makers, governments and international
agencies as contributing to child development, learning
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and socio-economic development. This includes FRESH
(Focus Resources on Effective School Health) whose
partners include Education International; Partnership for
Child Development; UNESCO; UNICEF; the World
Food Programme; the World Health Organization and
the World Bank. Results of this project will, therefore,
be of relevance to FRESH and local, national and inter-
national agencies.
Trial status
At the time of submission, the formative research has been
completed and recruitment was ongoing. Recruitment
started on 4 January 2017.
Additional files
Additional file 1: Example of a SightSim image generated by Peek simulating
the visual blur caused by uncorrected refractive error. (DOCX 1760 kb)
Additional file 2: SPIRIT checklist. (PDF 36 kb)
Abbreviations
App: Application; Peek: Portable Eye Examination Kit; RE: Refractive error;
uRE: Uncorrected refractive error; VA: Visual acuity
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